Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
Year: 2018
Type: article
Abstract: Tau immunotherapies have now advanced from proof-of-concept studies to Phase 2 clinical trials.This review briefly outlines developments in the field and discusses how these therapies may work, which involves multiple variables that are connected in complex ways.These various factors are likely to define therapeutic success in humans and have not been thoroughly investigated, at least based on published reports.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-189010
Author: Einar M. Sigurdsson
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: tau immunotherapy, Alzheimer's disease
Open Access status: bronze
OpenAlex ID: W2809673889
